DCGI orders suspension of Serum's India trials of AstraZeneca's COVID-19 vaccine

India's drug regulator has asked Serum Institute of India to suspend recruitment in its clinical trials of AstraZeneca Plc's potential COVID-19 vaccine in the country until further orders, Reuters partner ANI reported on Friday.

from bdnews24.com - Home https://ift.tt/35sGsO3